source
- Stakeholders call on FDA to set safety and treatment standards for emerging psychedelic therapiesAt a recent public hearing, experts and other stakeholders emphasized the need for clear safety and access guidelines as psychedelic medicines move closer to market. The FDA is intensifying effort…
- Cullinan-Taiho eye FDA filing for zipalertinib after trial shows strong PFS benefit despite three deathsCullinan Therapeutics and its partner Taiho Oncology said they will seek FDA approval for zipalertinib, an oral therapy for a subset of non‑small cell lung cancer, based on data from a late‑stage s…